Safety, Tolerability, and Pharmacokinetics, of Single and Multiple Ascending Doses of FP-020 in Healthy Adult Volunteers
Clinical trial NCT06334211 · COMPLETED
Trial details
- NCT number
- NCT06334211
- Sponsor
- Foresee Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2024-09-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.